DIN 02444186 — BREO ELLIPTA 200 MCG; 25 MCG
BREO ELLIPTA is a powder of Fluticasone Furoate / Vilanterol marketed by GLAXOSMITHKLINE INC. The full Fluticasone Furoate / Vilanterol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02444186
- Brand name
- BREO ELLIPTA
- Active ingredient
- Fluticasone Furoate / Vilanterol
- Strength
- 200 MCG; 25 MCG
- Dosage form
- POWDER
- Route
- INHALATION
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Inhaled corticosteroid (ICS) / long-acting beta2-adrenergic agonist (LABA) combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Fluticasone Furoate / Vilanterol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02408872 | BREO ELLIPTA | 100 MCG; 25 MCG | POWDER | GLAXOSMITHKLINE INC | MARKETED |